Medical Genetics
Fragile X Syndrome
Confirm suspected fragile X syndrome with dedicated FMR1 CGG-repeat and methylation testing, distinguish full mutation from premutation states, and use the result to direct developmental care, symptom-targeted treatment, and cascade reproductive counseling.
Diagnostic trigger
Order targeted FMR1 testing when the phenotype or pedigree is suggestive
Testing should resolve a specific FMR1-related diagnostic or reproductive question.
Order dedicated FMR1 molecular testing for unexplained developmental delay, intellectual disability, autism-spectrum features, or a family history compatible with fragile X syndrome or another FMR1-related disorder. Males may have substantial developmental delay before recognizable physical features emerge; females may have milder developmental impairment. publications aappublications aapFragile X Syndrome (Chapter 253) | American Academy of Pediatrics Textbook of Pediatric Care | Pediatric Care Online | American Academy of Pediatrics
Do not use a negative routine multigene panel, exome, or genome result to exclude fragile X syndrome. These approaches are useful when no CGG-repeat expansion is detected but clinical suspicion persists, whereas FMR1 disorders require specialized molecular testing for the CGG expansion. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf
In an adult with intention tremor, gait ataxia, or a family history of FMR1 expansion, distinguish fragile X-associated tremor/ataxia syndrome from full-mutation fragile X syndrome by FMR1 repeat category. In a woman with ovarian insufficiency or reproductive counseling needs, determine whether a premutation is present because premutation status is associated with fragile X-associated primary ovarian insufficiency. PubMed+1PubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelfpublications aapFragile X Syndrome (Chapter 253) | American Academy of Pediatrics Textbook of Pediatric Care | Pediatric Care Online | American Academy of Pediatrics
Use FMR1-specific CGG-repeat expansion testing as the first molecular test when fragile X syndrome is suspected. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf
Obtain a three-generation pedigree that includes intellectual disability, autism-spectrum diagnoses, tremor/ataxia, ovarian insufficiency, and known FMR1 results. FMR1-related disorders include fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency. publications aap+1publications aapFragile X Syndrome (Chapter 253) | American Academy of Pediatrics Textbook of Pediatric Care | Pediatric Care Online | American Academy of PediatricsPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf
Refer confirmed or suspected expansion carriers for genetic counseling before reproductive decisions; maternal premutation alleles can expand to full mutations during intergenerational transmission. PubMed+1PubMedFMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome - PMCPubMedExpansion of the Fragile X CGG Repeat in Females with Premutation or Intermediate Alleles - PMC
| FMR1 result | Interpretation | Clinical next step |
|---|---|---|
| Normal: 5-44 CGG repeats | Does not indicate fragile X syndrome or increased transmission risk for fragile X syndrome. CDCCDCHow Fragile X Syndrome Is Inherited | Fragile X Syndrome (FXS) | CDC | Pursue alternative etiologies if the phenotype remains unexplained. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf |
| Intermediate: 45-54 CGG repeats | Does not establish fragile X syndrome and is not considered a risk for having a child with fragile X syndrome. CDCCDCHow Fragile X Syndrome Is Inherited | Fragile X Syndrome (FXS) | CDC | Document the result and individualize counseling for family context and laboratory interpretation. CDCCDCHow Fragile X Syndrome Is Inherited | Fragile X Syndrome (FXS) | CDC |
| Premutation: approximately 55-200 CGG repeats | Usually unmethylated; associated with risk for fragile X-associated tremor/ataxia syndrome and, in females, fragile X-associated primary ovarian insufficiency. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf | Provide genetic counseling, assess the relevant adult phenotype, and discuss transmission risk. PubMed+1PubMedFMR1 Disorders - GeneReviews® - NCBI BookshelfCDCHow Fragile X Syndrome Is Inherited | Fragile X Syndrome (FXS) | CDC |
| Full mutation: more than 200 CGG repeats | Usually associated with FMR1 methylation and loss of FMR1 protein expression; establishes fragile X syndrome when clinically concordant. PubMed+1PubMedFMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome - PMCPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf | Initiate syndrome-specific developmental, behavioral, and medical surveillance and offer cascade family evaluation. publications aap+1publications aapHealth Supervision for Children With Fragile X SyndromePubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf |
| Repeat-size or methylation mosaicism | Mixed premutation/full-mutation or methylated/unmethylated cell lines can produce variable neurodevelopmental function. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf | Use the complete laboratory interpretation and clinical phenotype for counseling rather than repeat count alone. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf |
Laboratory interpretation
Interpret repeat size, methylation, and mosaicism together
The actionable result is the FMR1 molecular category, not a nonspecific sequencing finding.
A definite molecular diagnosis of fragile X syndrome generally requires a full mutation exceeding 200 CGG repeats. These alleles are typically methylated, whereas premutation alleles of approximately 55-200 repeats are generally unmethylated. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf
Use an assay that can define expansion status and address methylation when a large expansion or mosaicism is possible. Repeat-primed PCR detects and localizes AGG interruptions; Southern blot detects normal alleles, larger premutations, and full mutations and determines FMR1 promoter methylation status. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf
Interpret phenotype by sex and molecular state. GeneReviews reports intellectual disability in essentially all males with a completely methylated full mutation and in about half of females with a full mutation; both repeat-size mosaicism and methylation mosaicism produce a broader functional range. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf
If targeted testing shows no CGG expansion but the patient remains clinically suspicious for a genetic neurodevelopmental disorder, proceed with broader genomic evaluation rather than relabeling the patient as having fragile X syndrome. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf
Request the laboratory report’s repeat-size category and methylation interpretation, especially for full mutations and suspected mosaicism. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf
Use AGG-interruption information, when reported, as a reproductive-counseling modifier rather than as a diagnostic substitute for repeat category. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf
Treat a premutation result as an FMR1-related disorder risk state, not as evidence that the patient has full-mutation fragile X syndrome. PubMed+1PubMedFMR1 Disorders - GeneReviews® - NCBI BookshelfCDCHow Fragile X Syndrome Is Inherited | Fragile X Syndrome (FXS) | CDC
| Method | Useful result | Decision use |
|---|---|---|
| Repeat-primed PCR | Detects CGG-repeat expansion and identifies AGG interspersions. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf | Use for targeted FMR1 expansion detection and reproductive-risk characterization when AGG structure is relevant. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf |
| Southern blot | Detects normal, larger premutation, and full-mutation alleles and determines promoter methylation. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf | Use when methylation status or large-expansion characterization is needed. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf |
| Multigene panel, exome, or genome testing | May identify alternative etiologies but is useful for fragile X evaluation only when no CGG expansion is detected and suspicion remains. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf | Do not substitute for targeted FMR1 expansion testing. PubMedPubMedFMR1 Disorders - GeneReviews® - NCBI Bookshelf |
Longitudinal care
Organize care around developmental function and treatable comorbidities
There is no established disease-modifying clinical therapy; management targets function and comorbidity.
After DNA confirmation, arrange age-appropriate developmental and educational intervention rather than waiting for physical features to evolve. Early intervention can improve long-term cognitive outcomes, although it should not be presented as restoring normal cognitive outcome. Nature+1NatureMain Report | Genetics in Medicinepublications aapHealth Supervision for Children With Fragile X Syndrome
At follow-up, actively identify impairment from ADHD symptoms, anxiety, aggression, and sleep problems because these are recognized medication targets in fragile X syndrome. Select medication according to the dominant treatable syndrome and reassess functional benefit and adverse effects rather than treating the molecular diagnosis itself. WileyWileyState‐of‐the‐art therapies for fragile X syndrome
Assess for seizures when episodes suggest altered awareness, motor events, or unexplained regression. ADHD and epilepsy may coexist in fragile X syndrome; stimulant therapy and antiseizure treatment can be managed independently when both disorders are present. Oxford Academic+1Oxford Academic58 Attention-Deficit Disorders and Epilepsy - Oxford AcademicWileyDescriptive analysis of seizures and comorbidities ...
Use a multidisciplinary model that links the primary clinician, developmental and behavioral services, school supports, and genetics. The AAP health-supervision guidance is specifically designed for pediatric management after DNA confirmation. publications aappublications aapHealth Supervision for Children With Fragile X Syndrome
Document baseline communication, adaptive function, behavior, sleep, and school or work participation; use these domains to judge whether a symptom-directed intervention is helping. Wiley+1WileyState‐of‐the‐art therapies for fragile X syndromepublications aapHealth Supervision for Children With Fragile X Syndrome
Evaluate suspected seizure events with a seizure-focused history and neurologic assessment; treat confirmed epilepsy with antiseizure therapy while independently addressing clinically significant ADHD. Oxford Academic+1Oxford Academic58 Attention-Deficit Disorders and Epilepsy - Oxford AcademicWileyDescriptive analysis of seizures and comorbidities ...
Review adverse effects whenever stimulants, antidepressants, or antipsychotics are used, because these agents may suppress symptoms without correcting the underlying molecular disorder and can cause side effects. cellcellGene therapy using an ortholog of human fragile X mental ...
Medication decisions
Pharmacotherapy in fragile X syndrome is symptom-directed: reported targets include ADHD symptoms, anxiety, aggression, and sleep problems. Stimulants, antidepressants, and antipsychotics may reduce symptoms but do not address the underlying FMR1 molecular defect. cell+1cellGene therapy using an ortholog of human fragile X mental ...WileyState‐of‐the‐art therapies for fragile X syndrome
Do not represent symptomatic psychotropic treatment as disease-modifying therapy. cell+1cellGene therapy using an ortholog of human fragile X mental ...WileyGene Therapy for Fragile X Syndrome, Challenges, and ...
Match medication choice to a defined target syndrome and track target behavior, function, and adverse effects at each reassessment. cell+1cellGene therapy using an ortholog of human fragile X mental ...WileyState‐of‐the‐art therapies for fragile X syndrome
Cascade care
Use the molecular result to counsel relatives and reproductive risk
A positive FMR1 result changes care beyond the proband.
Counsel families that fragile X syndrome results from CGG-repeat hyperexpansion in the 5′ untranslated region of FMR1, which leads to promoter hypermethylation and loss of the encoded protein in full-mutation disease. PubMed+1PubMedFMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome - PMCPubMedFMR1 premutation and full mutation molecular mechanisms ...
For a woman with a premutation, explain that the allele may expand to a full mutation during maternal transmission. Repeat length and AGG interruptions influence expansion behavior; expansion from premutation to full mutation has been documented in one generation, including a 59-repeat allele lacking AGG interruptions in a pedigree analysis. PubMed+1PubMedFMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome - PMCPubMedExpansion of the Fragile X CGG Repeat in Females with Premutation or Intermediate Alleles - PMC
Offer targeted testing and counseling to biologically relevant relatives after identifying a full mutation or premutation. This can identify relatives at risk for fragile X syndrome, fragile X-associated tremor/ataxia syndrome, or fragile X-associated primary ovarian insufficiency and can inform reproductive planning. publications aap+2publications aapFragile X Syndrome (Chapter 253) | American Academy of Pediatrics Textbook of Pediatric Care | Pediatric Care Online | American Academy of PediatricsPubMedFMR1 Disorders - GeneReviews® - NCBI BookshelfCDCHow Fragile X Syndrome Is Inherited | Fragile X Syndrome (FXS) | CDC
When reproductive options are being considered, refer to reproductive genetics. Preimplantation genetic testing has used FMR1 PCR-based approaches, but large GC-rich premutation and full-mutation alleles can be difficult to amplify; linked-marker approaches may be needed to reduce misclassification risk. PubMedPubMedFMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome - PMC
Classify each tested relative by the largest FMR1 allele when interpreting female results, because females have two FMR1 copies and category assignment is based on the larger repeat number. CDCCDCHow Fragile X Syndrome Is Inherited | Fragile X Syndrome (FXS) | CDC
Do not reassure a premutation carrier solely because they do not have fragile X syndrome; counsel regarding adult FMR1-associated risks and transmission implications. PubMed+1PubMedFMR1 Disorders - GeneReviews® - NCBI BookshelfCDCHow Fragile X Syndrome Is Inherited | Fragile X Syndrome (FXS) | CDC
Use reproductive genetics consultation for premutation or full-mutation carriers considering pregnancy, preimplantation testing, or prenatal diagnostic options. PubMed+1PubMedFMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome - PMCPubMedExpansion of the Fragile X CGG Repeat in Females with Premutation or Intermediate Alleles - PMC
References
- Attention deficit hyperactivity disorder — adc.bmj.com · adc.bmj.com
- ACMG Statements and Guidelines — www.nature.com · www.nature.com
- ACMG Standards and Guidelines for fragile X testing — www.nature.com · www.nature.com
- Main Report | Genetics in Medicine — www.nature.com · www.nature.com
- Neonatal expression of human FMRP isoform corrects ... — www.cell.com · www.cell.com
- Gene therapy using an ortholog of human fragile X mental ... — www.cell.com · www.cell.com
- FMR1 mutant marmosets show fragile X syndrome ... — www.cell.com · www.cell.com
- State‐of‐the‐art therapies for fragile X syndrome — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Gene Therapy for Fragile X Syndrome, Challenges, and ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- A multidisciplinary approach to the management of ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- 58 Attention-Deficit Disorders and Epilepsy - Oxford Academic — academic.oup.com · academic.oup.com
- Descriptive analysis of seizures and comorbidities ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Fragile X‐associated tremor/ataxia syndrome: Clinical ... — movementdisorders.onlinelibrary.wiley.com · movementdisorders.onlinelibrary.wiley.com
- Health Supervision for Children With Fragile X Syndrome — publications.aap.org · publications.aap.org
- Fragile X Syndrome (Chapter 253) | American Academy of Pediatrics Textbook of Pediatric Care | Pediatric Care Online | American Academy of Pediatrics — publications.aap.org · publications.aap.org
- Chapter 107: The Newborn with Neurologic Findings — publications.aap.org · publications.aap.org
- Ethical, Legal, and Social Concerns About Expanded ... — publications.aap.org · publications.aap.org
- FMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- FMR1 Disorders - GeneReviews® - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Development of Genetic Testing for Fragile X Syndrome and ... — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- FMR1 premutation and full mutation molecular mechanisms ... — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Expansion of the Fragile X CGG Repeat in Females with Premutation or Intermediate Alleles - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- How Fragile X Syndrome Is Inherited | Fragile X Syndrome (FXS) | CDC — www.cdc.gov · www.cdc.gov
- A methylation PCR approach for detection of fragile X ... — pubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov